CAS No.:51-06-9
Name: Procainamide
Details Introduction
TOXICITY DATA with REFERENCE:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LD50 | intravenous | 170mg/kg (170mg/kg) | Polish Journal of Pharmacology and Pharmacy. Vol. 32, Pg. 833, 1980. | |
| dog | LDLo | oral | 2210mg/kg (2210mg/kg) | Toxicology and Applied Pharmacology. Vol. 21, Pg. 253, 1972. | |
| guinea pig | LD50 | intravenous | 280mg/kg (280mg/kg) | Farmaco, Edizione Scientifica. Vol. 12, Pg. 77, 1957. | |
| human | TDLo | oral | 2280mg/kg/22W (2280mg/kg) | MUSCULOSKELETAL: JOINTS | British Heart Journal. Vol. 34, Pg. 284, 1972. |
| man | TDLo | intravenous | 583mg/kg/12D- (583mg/kg) | CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) | American Heart Journal. Vol. 109, Pg. 375, 1985. |
| man | TDLo | oral | 29mg/kg (29mg/kg) | BEHAVIORAL: TREMOR | American Journal of Cardiology. Vol. 57, Pg. 340, 1986. |
| man | TDLo | oral | 8579mg/kg/43W (8579mg/kg) | LUNGS, THORAX, OR RESPIRATION: FIBROSING ALVEOLITIS | American Journal of Medicine. Vol. 76, Pg. 146, 1984. |
| man | TDLo | unreported | 31gm/kg/3Y-I (31000mg/kg) | VASCULAR: STRICTIRA; CJAMGES OM VESSE;S SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Clinical and Experimental Rheumatology. Vol. 4, Pg. 290, 1986. |
| mouse | LD50 | intraperitoneal | 178mg/kg (178mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA |
Polish Journal of Pharmacology and Pharmacy. Vol. 37, Pg. 551, 1985. |
| mouse | LD50 | intravenous | 49mg/kg (49mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA |
Polish Journal of Pharmacology and Pharmacy. Vol. 37, Pg. 551, 1985. |
| mouse | LD50 | oral | 525mg/kg (525mg/kg) | Collection of Czechoslovak Chemical Communications. Vol. 42, Pg. 3628, 1977. | |
| mouse | LD50 | subcutaneous | 720mg/kg (720mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA |
Polish Journal of Pharmacology and Pharmacy. Vol. 37, Pg. 551, 1985. |
| rabbit | LD50 | intravenous | 125mg/kg (125mg/kg) | Polish Journal of Pharmacology and Pharmacy. Vol. 32, Pg. 833, 1980. | |
| rat | LD50 | intravenous | 110mg/kg (110mg/kg) | Russian Pharmacology and Toxicology Vol. 33, Pg. 292, 1970. | |
| rat | LD50 | oral | 1950mg/kg (1950mg/kg) | Collection of Czechoslovak Chemical Communications. Vol. 42, Pg. 3628, 1977. | |
| rat | LD50 | unreported | 110mg/kg (110mg/kg) | Farmakologiya i Toksikologiya Vol. 54(3), Pg. 32, 1991. | |
| women | TDLo | oral | 1120mg/kg/4W- (1120mg/kg) | BEHAVIORAL: WAKEFULNESS BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TOXIC PSYCHOSIS |
American Journal of Psychiatry. Vol. 145, Pg. 129, 1988. |
| women | TDLo | oral | 1826mg/kg/13W (1826mg/kg) | CARDIAC: OTHER CHANGES | American Heart Journal. Vol. 83, Pg. 798, 1972. |
Consensus Reports:
SAFETY PROFILE:
Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion. Human systemic effects by ingestion: cardiac abnormalities, joint effects, cough, tremors, dyspnea, and other lung effects. When heated to decomposition it emits toxic fumes of NOx.
Standards and Recommendations:
Analytical Methods:
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione


